Get the Stockscreener App
1.0637
0.95%
0.0137
Canopy Growth Corporation stock is traded at $1.0637, with a volume of 3.53M.
It is up +0.95% in the last 24 hours and up +19.29% over the past month.
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
See More
Previous Close:
$1.05
Open:
$1.05
24h Volume:
3.53M
Relative Volume:
0.73
Market Cap:
$478.50M
Revenue:
$199.30M
Net Income/Loss:
$-230.47M
P/E Ratio:
-0.8251
EPS:
-1.2891
Net Cash Flow:
$-58.89M
1W Performance:
+6.00%
1M Performance:
+19.29%
6M Performance:
-9.40%
1Y Performance:
-16.54%
1-Day Range:
$1.04
$1.075
1-Week Range:
$0.9873
$1.08
52-Week Range:
$0.8435
$2.38
Canopy Growth Corporation Stock (CGC) Company Profile
Name
Canopy Growth Corporation
Sector
Phone
855-558-9333
Address
1 Hershey Drive, Smiths Falls, ON
Compare CGC vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CGC
Canopy Growth Corporation
|
1.065 | 471.76M | 199.30M | -230.47M | -58.89M | -1.2891 |
TAK
Takeda Pharmaceutical Co Adr
|
18.23 | 57.90B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
10.16 | 43.41B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.92 | 42.89B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
77.62 | 31.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
513.58 | 22.35B | 3.17B | 1.29B | 1.01B | 27.09 |
Canopy Growth Corporation Stock (CGC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-27-26 | Initiated | Canaccord Genuity | Buy |
| Nov-10-25 | Upgrade | The Benchmark Company | Sell → Hold |
| Apr-04-23 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Nov-02-22 | Initiated | Bernstein | Underperform |
| Oct-26-22 | Upgrade | Canaccord Genuity | Sell → Hold |
| Jun-08-22 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| Mar-22-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Dec-22-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-20-21 | Downgrade | Piper Sandler | Neutral → Underweight |
| Dec-07-21 | Initiated | Wells Fargo | Underweight |
| Nov-18-21 | Initiated | Barclays | Equal Weight |
| Nov-08-21 | Downgrade | CIBC | Neutral → Sector Underperform |
| Nov-08-21 | Downgrade | Canaccord Genuity | Hold → Sell |
| Nov-08-21 | Downgrade | Cowen | Outperform → Market Perform |
| Oct-01-21 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-12-21 | Upgrade | Jefferies | Underperform → Hold |
| Jun-02-21 | Upgrade | Canaccord Genuity | Sell → Hold |
| May-25-21 | Upgrade | MKM Partners | Neutral → Buy |
| Apr-28-21 | Resumed | BofA Securities | Buy |
| Feb-24-21 | Downgrade | Jefferies | Hold → Underperform |
| Feb-10-21 | Downgrade | Canaccord Genuity | Hold → Sell |
| Feb-10-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Feb-05-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-04-20 | Upgrade | CFRA | Buy → Strong Buy |
| Jun-01-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Jun-01-20 | Downgrade | Bryan Garnier | Neutral → Sell |
| Jun-01-20 | Downgrade | CIBC | Sector Outperform → Neutral |
| Jun-01-20 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Jun-01-20 | Downgrade | Stifel | Buy → Sell |
| May-22-20 | Resumed | BofA/Merrill | Buy |
| Apr-16-20 | Upgrade | Jefferies | Underperform → Hold |
| Jan-28-20 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Dec-12-19 | Reiterated | Cantor Fitzgerald | Neutral |
| Nov-20-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Nov-15-19 | Downgrade | Alliance Global Partners | Buy → Neutral |
| Nov-05-19 | Initiated | Cantor Fitzgerald | Neutral |
| Oct-14-19 | Downgrade | Seaport Global Securities | Buy → Neutral |
| Oct-11-19 | Downgrade | Jefferies | Hold → Underperform |
| Sep-27-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Sep-20-19 | Initiated | MKM Partners | Neutral |
| Sep-18-19 | Initiated | Oppenheimer | Perform |
| Aug-26-19 | Upgrade | Seaport Global Securities | Neutral → Buy |
| Jul-17-19 | Initiated | Ladenburg Thalmann | Buy |
View All
Canopy Growth Corporation Stock (CGC) Latest News
Why Canopy Growth (NASDAQ:CGC) Faces New Industry Challenges? - Kalkine Media
Canopy Growth publishes FY2026 annual report - Bitget
Cannabis Operator CGC Rises 15% in a Month: Time to Buy, Hold or Sell? - The Globe and Mail
Curaleaf's Hostile Takeover Bid for Aurora Is Just the Tip of the Iceberg for Cannabis Consolidation. These 2 Stocks Could Be the Biggest Winners. - The Motley Fool
Why Is Canopy Growth (NASDAQ:CGC) Facing a Regulatory Test? - Kalkine Media
Canopy Growth (NASDAQ:CGC): Cannabis Industry Shifts in Focus - Kalkine Media
Why Is Canopy Growth (NASDAQ:CGC) in Focus Today? - Kalkine Media
What Does Today’s Federal Cannabis Update Mean for Canopy Growth (NASDAQ:CGC)? - Kalkine Media
How Is Canopy Growth (NASDAQ:CGC) Shaping Its Market Narrative? - Kalkine Media
Tilray Jumps 6%, Canopy Growth Climbs 3%, Aurora Cannabis Gains 4%: Here’s Why TLRY Is Still Down 47% YTD - Yahoo Finance
Canopy (CGC) Quarterly Results: The Available Earnings Metric Delivers a Beat in the Latest Reading; Trading Move: The Stock Records a 1.00% Decrease for the Current SessionGuidance Update - Vinanet
Why Is Canopy Growth (NASDAQ:CGC) Keeping Its European Door Open? - Kalkine Media
Curaleaf Advances Aurora Acquisition Strategy with Direct Shareholder Offer - stratcann.com
Canopy Growth Announces Mailing of Proxy Materials for 2026 Annual General and Special MeetingUrges Shareholders to Vote Now - marketscreener.com
How Is Canopy Growth (NASDAQ:CGC) Positioned as the Cannabis Sector Eyes Reform? - Kalkine Media
Could Fresh Cannabis Momentum Send Canopy Growth (TSX:WEED) Higher? - Kalkine Media
Canopy Growth (NASDAQ:CGC) Draws Attention Amid Acquisition Speculation - Kalkine Media
Canopy Growth schedules shareholder meeting for Sept. 25 - Investing.com
CGC Looks 50.0% Overvalued on GF Value™ - GuruFocus
Canopy Growth schedules shareholder meeting for Sept. 25 By Investing.com - Investing.com Canada
Canopy Growth sets annual shareholder meeting for September 25 - StreetInsider
Canopy Growth Announces Mailing of Proxy Materials for 2026 Annual General and Special Meeting – Urges Shareholders to Vote Now - The Globe and Mail
Canopy Growth (NASDAQ:CGC): Can Today’s Update Clarify Operating Reset? - Kalkine Media
Curaleaf Wants to Buy Aurora Cannabis for $272 Million. Is Canopy Growth the Next Marijuana Takeover Target? - Yahoo Finance
Canopy Growth (NASDAQ:CGC) stock in focus after revenue growth and margin gains - Kalkine Media
Week in Weed – August 15, 2026 - StratCann
Canopy Growth’s Kincardine Facility Secures EU-GMP Recertification - StratCann
What Is Driving Canopy Growth (TSX:WEED) Toward Better Margins? - Kalkine Media
Is Acquiring Aurora Cannabis a Good Move for Curaleaf? - AOL.com
Canopy Growth Secures Renewed EU GMP Certification at Kincardine Cultivation Facility - Cannabis Business Times
Canopy Growth Secures Renewed EU Gmp Certification At Kincardine As European Medical Cannabis Business Grows - TradingView
Canopy Growth Secures Renewed Eu Gmp Certification At Kincardine as European Medical Cannabis Business Grows - marketscreener.com
Canopy Growth renews EU certification for Ontario facility - Investing.com
Canopy Growth renews EU certification for Ontario facility By Investing.com - Investing.com Canada
Canopy Growth's Ontario Facility Receives Renewed EU GMP Certification - marketscreener.com
Canopy Growth Secures Renewed EU GMP Certification at Kincardine as European Medical Cannabis Business Grows - canopygrowth.com
Canopy Growth renews EU GMP certification for Ontario facility - StreetInsider
Canopy Growth Can Keep Supplying Canadian-Grown Medical Cannabis Across Europe - Stock Titan
Canopy Growth (NASDAQ:CGC) Follows A Closely Watched Quarterly Update - Kalkine Media
Canopy Growth (TSX:CGC) Innovation Strategy And Cannabis Formats - kalkinemedia.com
Why Is Canopy Growth (NASDAQ:CGC) In Focus as American Cannabis Rules Shift Worth Watching? - Kalkine Media
Will Canopy Growth Get Acquired? - The Motley Fool
Is Canopy Growth (TSX:WEED) Driving Cannabis Stocks Optimism Again? - Kalkine Media
Why Watch Canopy Growth (NASDAQ:CGC) as US Indices Near Records? - Kalkine Media
Canopy Growth Stock Extends Green Momentum as Revenue Growth and Margin Recovery Lift Investor Optimism - kalkine.ca
Earnings Release: Here's Why Analysts Cut Their Canopy Growth Corporation (TSE:WEED) Price Target To CA$2.02 - simplywall.st
Canopy Growth Corporation (NASDAQ:CGC) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Canopy Growth Targets European Cannabis Expansion After MTL Deal and Cost Cuts - MarketBeat
Curaleaf Just Announced a Hostile Takeover Bid for Aurora Cannabis. Here’s What This Means for Investors. - AOL.com
Is Canopy Growth (NASDAQ:CGC) the Cannabis Name Drawing Fresh Attention? - Kalkine Media
Canopy Growth (TSX:WEED) Cannabis Stocks Watch Margin Improvement Closely - Kalkine Media
Canopy Growth Corporation Stock (CGC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.78%
0.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):